The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract
Once the peptides are reconstituted (mixed with bacteriostatic water) , they must be stored in the refrigerator to maintain their stability
Rather than daily injections, the protocol requires a heavier 2.5 mg systemic dose injected twice per week
Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels [1] [2]
Proper vial handling technique is essential for maintaining sterility throughout the use period
Baltimore, Md.: Johns Hopkins University Press